MedTrace Logo

Radial Artery Occlusion and Dual Artery Hemostasis After Transradial Approach.

NCT04933136 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-03-10

No results posted yet for this study

Summary

* Improving patient comfort and implementing the protocols required to minimize the risk of RAO must be part of quality control.
* Several procedural parameters are related to the risk of RAO but hemostasis is a critical period.
* Despite the fact that non-occlusive hemostasis of the radial artery is a recognized and effective technique for reducing the risk of RAO, it is rarely practiced because it is tedious, involves additional care and is not always effective with current hemostasis systems.
* Prophylactic compression of the cubital artery during radial artery hemostasis has been shown to be effective in maintaining non-occlusive hemostasis but requires 2 devices and does not simplify care procedures.
* The Terry2™ band is a new dual device that offers effortless non-occlusive radial hemostasis and does not require repeated intervention by nursing staff.

The primary objectives of this observational study are to demonstrate the benefits, safety and impact on care of using Terry2™ band in patients undergoing diagnostic or interventional catheterization by radial (or ulnar) approach.

Conditions

  • Radial Artery Occlusion

Interventions

DEVICE

Terry2 Band

Hemostasis protocol following radial or cubital approach catheterization using the dual artery hemostasis device Terry2Band.

Sponsors & Collaborators

  • Laval University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-12
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04933136 on ClinicalTrials.gov